Selected article for: "chronic liver disease and current management"

Author: Zobeiri, Mehdi; Parvizi, Fatemeh; Kalhori, Mohammad Reza; Majnooni, Mohammad Bagher; Farzaei, Mohammad Hosein; Abdollahi, Mohammad
Title: Targeting miRNA by Natural Products: A Novel Therapeutic Approach for Nonalcoholic Fatty Liver
  • Cord-id: ps3ncdke
  • Document date: 2021_8_13
  • ID: ps3ncdke
    Snippet: The increasing prevalence of nonalcoholic fatty liver disease (NAFLD) as multifactorial chronic liver disease and the lack of a specific treatment have begun a new era in its treatment using gene expression changes and microRNAs. This study aimed to investigate the potential therapeutic effects of natural compounds in NAFLD by regulating miRNA expression. MicroRNAs play essential roles in regulating the cell's biological processes, such as apoptosis, migration, lipid metabolism, insulin resistan
    Document: The increasing prevalence of nonalcoholic fatty liver disease (NAFLD) as multifactorial chronic liver disease and the lack of a specific treatment have begun a new era in its treatment using gene expression changes and microRNAs. This study aimed to investigate the potential therapeutic effects of natural compounds in NAFLD by regulating miRNA expression. MicroRNAs play essential roles in regulating the cell's biological processes, such as apoptosis, migration, lipid metabolism, insulin resistance, and adipocyte differentiation, by controlling the posttranscriptional gene expression level. The impact of current NAFLD pharmacological management, including drug and biological therapies, is uncertain. In this context, various dietary fruits or medicinal herbal sources have received worldwide attention versus NAFLD development. Natural ingredients such as berberine, lychee pulp, grape seed, and rosemary possess protective and therapeutic effects against NAFLD by modifying the gene's expression and noncoding RNAs, especially miRNAs.

    Search related documents:
    Co phrase search for related documents
    • abnormal accumulation and acid oxidation fatty: 1
    • acc1 acetyl coa carboxylase and acetyl coa: 1
    • acc1 acetyl coa carboxylase and acetyl coa carboxylase: 1
    • acc1 acetyl coa carboxylase and acid synthase: 1
    • acc1 acetyl coa carboxylase expression and acetyl coa: 1
    • acc1 acetyl coa carboxylase expression and acetyl coa carboxylase: 1
    • acc1 acetyl coa carboxylase expression and acid synthase: 1
    • accumulation triglyceride and acetyl coa: 1
    • accumulation triglyceride and acetyl coa carboxylase: 1
    • accumulation triglyceride and acid oxidation: 1
    • accumulation triglyceride and acid oxidation fatty: 1
    • accumulation triglyceride and acid synthase: 1, 2
    • acetyl coa and acid oxidation: 1, 2, 3
    • acetyl coa and acid oxidation fatty: 1, 2, 3
    • acetyl coa and acid synthase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acetyl coa carboxylase and acid oxidation: 1
    • acetyl coa carboxylase and acid oxidation fatty: 1
    • acetyl coa carboxylase and acid synthase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acid oxidation and activity expression: 1, 2